| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |